Protein profiles in Tc1 mice implicate novel pathway perturbations in the Down syndrome brain, Human Molecular Genetics, vol.22, issue.9, pp.1709-1724, 2013. ,
DOI : 10.1093/hmg/ddt017
Protein Dynamics Associated with Failed and Rescued Learning in the Ts65Dn Mouse Model of Down Syndrome, PLOS ONE, vol.16, issue.1, 2015. ,
DOI : 10.1371/journal.pone.0119491.s004
DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects, Neurobiology of Disease, vol.22, issue.3, pp.463-472, 2006. ,
DOI : 10.1016/j.nbd.2005.12.006
Perturbed hematopoiesis in the Tc1 mouse model of Down syndrome, Blood, vol.115, issue.14, pp.2928-2937, 2010. ,
DOI : 10.1182/blood-2009-06-227629
Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome, Human Molecular Genetics, vol.10, issue.18, pp.1915-1923, 2001. ,
DOI : 10.1093/hmg/10.18.1915
Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome, Neurobiology of Disease, vol.52, pp.117-127, 2013. ,
DOI : 10.1016/j.nbd.2012.11.017
Rapamycin restores BDNF-LTP and the persistence of long-term memory in a model of Down's syndrome, Neurobiology of Disease, vol.82, pp.516-525, 2015. ,
DOI : 10.1016/j.nbd.2015.09.005
Down syndrome and the complexity of genome dosage imbalance, Nature Reviews Genetics, vol.110, issue.3, pp.147-163, 2016. ,
DOI : 10.1159/000084979
Chromosome 21 and down syndrome: from genomics to pathophysiology, Nature Reviews Genetics, vol.46, issue.10, pp.725-738, 2004. ,
DOI : 10.1002/dvdy.20079
Deletion of the App-Runx1 region in mice models human partial monosomy 21, Disease Models & Mechanisms, vol.8, issue.6, pp.623-634, 2015. ,
DOI : 10.1242/dmm.017814
Reciprocal Effects on Neurocognitive and Metabolic Phenotypes in Mouse Models of 16p11.2 Deletion and Duplication Syndromes, PLOS Genetics, vol.34, issue.3, 2016. ,
DOI : 10.1371/journal.pgen.1005709.s019
Maternal choline supplementation improves spatial mapping and increases basal forebrain cholinergic neuron number and size in aged Ts65Dn mice, Neurobiology of Disease, vol.70, pp.32-42, 2014. ,
DOI : 10.1016/j.nbd.2014.06.001
Dementia in Down's syndrome, The Lancet Neurology, vol.15, issue.6, pp.622-636, 2016. ,
DOI : 10.1016/S1474-4422(16)00063-6
Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse, Human Molecular Genetics, vol.9, issue.2, pp.195-202, 2000. ,
DOI : 10.1093/hmg/9.2.195
Aneuploidy Causes Non-genetic Individuality, Cell, vol.169, issue.2, pp.229-242, 2017. ,
DOI : 10.1016/j.cell.2017.03.021
Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic plasticity and spatial memory in a mouse model of Down Syndrome, Neurobiology of Disease, vol.63, pp.12-19, 2014. ,
DOI : 10.1016/j.nbd.2013.11.010
Early environmental therapy rescues brain development in a mouse model of Down syndrome, Neurobiology of Disease, vol.82, pp.409-419, 2015. ,
DOI : 10.1016/j.nbd.2015.07.014
The "Down Syndrome Critical Region" Is Sufficient in the Mouse Model to Confer Behavioral, Neurophysiological, and Synaptic Phenotypes Characteristic of Down Syndrome, Journal of Neuroscience, vol.29, issue.18, pp.5938-5948, 2009. ,
DOI : 10.1523/JNEUROSCI.1547-09.2009
Down Syndrome Cognitive Phenotypes Modeled in Mice Trisomic for All HSA 21 Homologues, PLOS ONE, vol.143, issue.7, 2015. ,
DOI : 10.1371/journal.pone.0134861.s001
An anti-beta-amyloid vaccine for treating cognitive deficits in a mouse model of Down syndrome, PLoS ONE, vol.11, 2016. ,
Modeling the monosomy for the telomeric part of human chromosome 21 reveals haploinsufficient genes modulating the inflammatory and airway responses, Human Molecular Genetics, vol.16, issue.17, pp.2040-2052, 2007. ,
DOI : 10.1093/hmg/ddm152
URL : https://hal.archives-ouvertes.fr/hal-00408331
Surveying the Down syndrome mouse model resource identifies critical regions responsible for chronic otitis media, Mammalian Genome, vol.19, issue.14, pp.439-445, 2013. ,
DOI : 10.1093/hmg/ddq179
Early Pharmacotherapy Restores Neurogenesis and Cognitive Performance in the Ts65Dn Mouse Model for Down Syndrome, Journal of Neuroscience, vol.30, issue.26, pp.8769-8779, 2010. ,
DOI : 10.1523/JNEUROSCI.0534-10.2010
Efficient and rapid generation of large genomic variants in rats and mice using CRISMERE, Scientific Reports, vol.17, p.43331, 2017. ,
DOI : 10.1038/nn.4235
Rescue of Synaptic Failure and Alleviation of Learning and Memory Impairments in a Trisomic Mouse Model of Down Syndrome, Journal of Neuropathology & Experimental Neurology, vol.70, issue.12, pp.1070-1079, 2011. ,
DOI : 10.1097/NEN.0b013e318236e9ad
Abnormal mineralization of the Ts65Dn Down syndrome mouse appendicular skeleton begins during embryonic development in a Dyrk1a-independent manner, Mechanisms of Development, vol.136, pp.133-142, 2015. ,
DOI : 10.1016/j.mod.2014.12.004
Transgenic Mouse In Vivo Library of Human Down Syndrome Critical Region 1, Journal of Neuropathology & Experimental Neurology, vol.63, issue.5, pp.429-440, 2004. ,
DOI : 10.1093/jnen/63.5.429
Chronic treatment with a promnesiant GABA-A alpha5-selective inverse agonist increases immediate early genes expression during memory processing in mice and rectifies their expression levels in a Down syndrome mouse model, Adv. Pharmacol. Sci, 2011. ,
Specific targeting of the GABA-A receptor alpha5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice, 2011. ,
Modeling Chromosomes in Mouse to Explore the Function of Genes, Genomic Disorders, and Chromosomal Organization, PLoS Genetics, vol.38, issue.7, p.86, 2006. ,
DOI : 10.1016/B978-012301463-4/50003-6
URL : https://hal.archives-ouvertes.fr/hal-00408337
Cre/loxP-Mediated Chromosome Engineering of the Mouse Genome, Handb. Exp. Pharmacol, vol.178, pp.29-48, 2007. ,
DOI : 10.1007/978-3-540-35109-2_2
URL : https://hal.archives-ouvertes.fr/hal-00408334
Opposite Phenotypes of Muscle Strength and Locomotor Function in Mouse Models of Partial Trisomy and Monosomy 21 for the Proximal Hspa13-App Region, PLOS Genetics, vol.1188, issue.3, 2015. ,
DOI : 10.1371/journal.pgen.1005062.s008
URL : https://hal.archives-ouvertes.fr/hal-01323519
Locomotor dysfonction and hypotonia in Down syndrome mouse models for the HSPA13- APP region as a consequence of dosage sensitive genes controlling muscular metabolism and mitochondrial function, Acta Physiol, vol.214, pp.11-12, 2015. ,
National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999???2001, Birth Defects Research Part A: Clinical and Molecular Teratology, vol.151, issue.11, pp.747-756, 1999. ,
DOI : 10.1001/archpedi.1997.02170480026004
Endocytic Pathway Abnormalities Precede Amyloid ?? Deposition in Sporadic Alzheimer???s Disease and Down Syndrome, The American Journal of Pathology, vol.157, issue.1, pp.277-286, 2000. ,
DOI : 10.1016/S0002-9440(10)64538-5
Age-related changes in memory and in acetylcholine functions in the hippocampus in the Ts65Dn mouse, a model of Down syndrome, Neurobiology of Learning and Memory, vol.89, issue.2, pp.167-177, 2008. ,
DOI : 10.1016/j.nlm.2007.05.007
TRACER: a resource to study the regulatory architecture of the mouse genome, BMC Genomics, vol.14, issue.1, p.215, 2013. ,
DOI : 10.1101/gr.122879.111
Dissecting Alzheimer disease in Down syndrome using mouse models, Frontiers in Behavioral Neuroscience, vol.31, issue.88, p.268, 2015. ,
DOI : 10.3233/JAD-2012-120073
Assessing rodent hippocampal involvement in the novel object recognition task. A review, Behavioural Brain Research, vol.285, pp.105-117, 2015. ,
DOI : 10.1016/j.bbr.2014.08.002
receptor antagonist pentylenetetrazole produces a sustained pro-cognitive benefit in a mouse model of Down's syndrome, British Journal of Pharmacology, vol.19, issue.Suppl. 1, pp.963-973, 2013. ,
DOI : 10.1093/hmg/ddq179
Lithium rescues synaptic plasticity and memory in Down syndrome mice, Journal of Clinical Investigation, vol.123, issue.1, 2013. ,
DOI : 10.1172/JCI64650DS1
Trisomy of the G protein-coupled K+ channel gene, Kcnj6, affects reward mechanisms, cognitive functions, and synaptic plasticity in mice, Proc. Natl. Acad. Sci. USA, pp.2642-2647, 2012. ,
DOI : 10.1038/mp.2010.64
Long-term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle-aged Ts65Dn mice, a model of Down syndrome, Journal of Pineal Research, vol.93, issue.3, pp.346-358, 2013. ,
DOI : 10.1073/pnas.93.23.13333
Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of Down syndrome, Journal of Pineal Research, vol.22, issue.1, pp.51-61, 2014. ,
DOI : 10.1096/fj.07-9574LSF
Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: A model of Down syndrome, Neuroscience Letters, vol.382, issue.3, pp.317-322, 2005. ,
DOI : 10.1016/j.neulet.2005.03.031
Acute Injections of the NMDA Receptor Antagonist Memantine Rescue Performance Deficits of the Ts65Dn Mouse Model of Down Syndrome on a Fear Conditioning Test, Neuropsychopharmacology, vol.41, issue.7, pp.1624-1632, 2008. ,
DOI : 10.1016/j.phrs.2004.05.005
Formoterol, a Long-Acting ??2 Adrenergic Agonist, Improves Cognitive Function and Promotes Dendritic Complexity in a Mouse Model of Down Syndrome, Biological Psychiatry, vol.75, issue.3, pp.179-188, 2014. ,
DOI : 10.1016/j.biopsych.2013.05.024
The use of mouse models to understand and improve cognitive deficits in Down syndrome, Disease Models & Mechanisms, vol.4, issue.5, pp.596-606, 2011. ,
DOI : 10.1242/dmm.007716
Hedgehog Agonist Therapy Corrects Structural and Cognitive Deficits in a Down Syndrome Mouse Model, Science Translational Medicine, vol.59, issue.5329, pp.201-120, 2013. ,
DOI : 10.1016/j.neuron.2008.05.023
Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome, Prog. Clin. Biol. Res, vol.360, pp.263-280, 1990. ,
Live births, natural losses, and elective terminations with Down syndrome in Massachusetts, Genetics in Medicine, vol.113, issue.5, pp.459-466, 2016. ,
DOI : 10.1016/j.ajog.2012.08.033
Molecular Mapping of Twenty-Four Features of Down Syndrome on Chromosome 21, European Journal of Human Genetics, vol.1, issue.2, pp.114-124, 1993. ,
DOI : 10.1159/000472398
Applications of the Morris water maze in the study of learning and memory, Brain Res. Rev, vol.36, pp.60-90, 2001. ,
DYRK1A (Dual-Specificity Tyrosine-Phosphorylated and -Regulated Kinase 1A): A Gene with Dosage Effect During Development and Neurogenesis, The Scientific World JOURNAL, vol.6, pp.1911-1922, 2006. ,
DOI : 10.1100/tsw.2006.319
Aneuploidy: From a Physiological Mechanism of Variance to Down Syndrome, Physiological Reviews, vol.89, issue.3, pp.887-920, 2009. ,
DOI : 10.1152/physrev.00032.2007
URL : https://hal.archives-ouvertes.fr/hal-00408268
Trans-acting epigenetic effects of chromosomal aneuploidies: lessons from Down syndrome and mouse models, Epigenomics, vol.401, issue.6751, pp.189-207, 2017. ,
DOI : 10.1186/s12864-015-1687-x
Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome, Neuroscience Letters, vol.413, issue.1, pp.77-81, 2007. ,
DOI : 10.1016/j.neulet.2006.11.026
DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome, Frontiers in Behavioral Neuroscience, vol.18, issue.47, p.104, 2016. ,
DOI : 10.1002/ddrr.1128
Inducing Segmental Aneuploid Mosaicism in the Mouse Through Targeted Asymmetric Sister Chromatid Event of Recombination, Genetics, vol.180, issue.1, pp.51-59, 2008. ,
DOI : 10.1534/genetics.108.092312
URL : https://hal.archives-ouvertes.fr/hal-00408291
The telomeric part of the human chromosome 21 from Cstb to Prmt2 is not necessary for the locomotor and short-term memory deficits observed in the Tc1 mouse model of Down syndrome, Behavioural Brain Research, vol.217, issue.2, pp.271-281, 2011. ,
DOI : 10.1016/j.bbr.2010.10.023
Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling down syndrome, Mammalian Genome, vol.6, issue.11, pp.674-684, 2011. ,
DOI : 10.1111/j.1601-183X.2006.00256.x
Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome, Nature Neuroscience, vol.313, pp.411-413, 2007. ,
DOI : 10.1001/jama.1953.02940310028007
Designer Receptors Enhance Memory in a Mouse Model of Down Syndrome, Journal of Neuroscience, vol.35, issue.4, pp.1343-1353, 2015. ,
DOI : 10.1523/JNEUROSCI.2658-14.2015
Overexpression of Dyrk1A Is Implicated in Several Cognitive, Electrophysiological and Neuromorphological Alterations Found in a Mouse Model of Down Syndrome, PLoS ONE, vol.29, issue.9, 2014. ,
DOI : 10.1371/journal.pone.0106572.t002
Age-Related Changes of Adaptive and Neuropsychological Features in Persons with Down Syndrome, PLoS ONE, vol.6, issue.3, 2014. ,
DOI : 10.1371/journal.pone.0113111.s003
Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome, Neurobiology of Disease, vol.82, pp.385-396, 2015. ,
DOI : 10.1016/j.nbd.2015.08.001
Absence of Prenatal Forebrain Defects in the Dp(16)1Yey/+ Mouse Model of Down Syndrome, Journal of Neuroscience, vol.36, issue.10, pp.2926-2944, 2016. ,
DOI : 10.1523/JNEUROSCI.2513-15.2016
Loss of Cholinergic Phenotype in Basal Forebrain Coincides with Cognitive Decline in a Mouse Model of Down's Syndrome, Experimental Neurology, vol.161, issue.2, pp.647-663, 2000. ,
DOI : 10.1006/exnr.1999.7289
Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndrome, Hippocampus, vol.2, issue.8, pp.905-914, 2003. ,
DOI : 10.1111/j.1749-6632.1991.tb00218.x
DYRK1A-mediated phosphorylation of GluN2A at Ser(1048) regulates the surface expression and channel activity of GluN1/GluN2A receptors, Front. Cell Neurosci, vol.8, p.331, 2014. ,
Massively Parallel Sequencing Reveals the Complex Structure of an Irradiated Human Chromosome on a Mouse Background in the Tc1 Model of Down Syndrome, PLoS ONE, vol.319, issue.4, p.60482, 2013. ,
DOI : 10.1371/journal.pone.0060482.s013
Animal model of human disease Autosomal trisomy, developmental impairment and fetal death, Am. J. Pathol, vol.77, pp.539-542, 1974. ,
Systematic approach to the study of trisomy in the mouse. II, Cytogenetic and Genome Research, vol.14, issue.1, pp.42-62, 1975. ,
DOI : 10.1159/000130318
Green Tea Polyphenols Rescue of Brain Defects Induced by Overexpression of DYRK1A, PLoS ONE, vol.21, issue.25, p.4606, 2009. ,
DOI : 10.1371/journal.pone.0004606.s001
DYRK1A: A master regulatory protein controlling brain growth, Neurobiology of Disease, vol.46, issue.1, pp.190-203, 2012. ,
DOI : 10.1016/j.nbd.2012.01.007
An Integrated Human/Murine Transcriptome and Pathway Approach To Identify Prenatal Treatments For Down Syndrome, Scientific Reports, vol.379, issue.1, p.32353, 2016. ,
DOI : 10.1016/S0140-6736(11)61676-0
Prenatal pharmacotherapy rescues brain development in a Down???s syndrome mouse model, Brain, vol.137, issue.2, pp.380-401, 2014. ,
DOI : 10.1093/brain/awt340
Mouse models of Down syndrome: gene content and consequences, Mammalian Genome, vol.2, issue.3940, pp.538-555, 2016. ,
DOI : 10.1016/j.celrep.2012.06.010
Size Does Not Always Matter: Ts65Dn Down Syndrome Mice Show Cerebellum-Dependent Motor Learning Deficits that Cannot Be Rescued by Postnatal SAG Treatment, Journal of Neuroscience, vol.33, issue.39, pp.15408-15413, 2013. ,
DOI : 10.1523/JNEUROSCI.2198-13.2013
Alterations to Dendritic Spine Morphology, but Not Dendrite Patterning, of Cortical Projection Neurons in Tc1 and Ts1Rhr Mouse Models of Down Syndrome, PLoS ONE, vol.106, issue.10, p.78561, 2013. ,
DOI : 10.1371/journal.pone.0078561.g005
Tc1 mouse model of trisomy-21 dissociates properties of short- and long-term recognition memory, Neurobiology of Learning and Memory, vol.130, pp.118-128, 2016. ,
DOI : 10.1016/j.nlm.2016.02.002
GluN2B Antagonism Affects Interneurons and Leads to Immediate and Persistent Changes in Synaptic Plasticity, Oscillations, and Behavior, Neuropsychopharmacology, vol.47, issue.7, pp.1221-1233, 2013. ,
DOI : 10.1016/j.neuropharm.2004.03.011
Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology, Current Alzheimer Research, vol.13, issue.1, 2015. ,
DOI : 10.2174/1567205012666151020114607
Adult-Onset Fluoxetine Treatment Does Not Improve Behavioral Impairments and May Have Adverse Effects on the Ts65Dn Mouse Model of Down Syndrome, Neural Plasticity, vol.20, issue.24, p.467251, 2012. ,
DOI : 10.1523/JNEUROSCI.0534-10.2010
Engineering chromosomes in mice through targeted meiotic recombination (TAMERE), Nat. Genet, vol.20, pp.381-384, 1998. ,
The in vivo Down syndrome genomic library in mouse, Prog. Brain Res, vol.197, pp.169-197, 2012. ,
DOI : 10.1016/B978-0-444-54299-1.00009-1
The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory, Neuroscience & Biobehavioral Reviews, vol.28, issue.5, pp.497-505, 2004. ,
DOI : 10.1016/j.neubiorev.2004.06.006
Minocycline prevents cholinergic loss in a mouse model of Down's syndrome, Annals of Neurology, vol.65, issue.5, pp.675-688, 2004. ,
DOI : 10.1212/01.WNL.0000049936.85487.7A
Behavioral and neurobiological markers of Alzheimer???s disease in Ts65Dn mice: effects of estrogen, Neurobiology of Aging, vol.25, issue.7, pp.873-884, 2004. ,
DOI : 10.1016/j.neurobiolaging.2003.10.010
Cystathionine ??-synthase is enriched in the brains of Down???s patients, Biochemical and Biophysical Research Communications, vol.338, issue.3, pp.1547-1550, 2005. ,
DOI : 10.1016/j.bbrc.2005.10.118
Prevention of Learning Deficit in a Down Syndrome Model, Obstetrics & Gynecology, vol.117, issue.2, Part 1, pp.354-361, 2011. ,
DOI : 10.1097/AOG.0b013e3182051ca5
Prenatal Treatment Prevents Learning Deficit in Down Syndrome Model, PLoS ONE, vol.108, issue.11, p.50724, 2012. ,
DOI : 10.1371/journal.pone.0050724.g001
Prenatal testing for Down syndrome: The perspectives of parents of individuals with Down syndrome, American Journal of Medical Genetics Part A, vol.29, issue.4, pp.743-750, 2012. ,
DOI : 10.1016/S1701-2163(16)32501-4
Hedgehog Signaling in Development and Cancer, Developmental Cell, vol.15, issue.6, pp.801-812, 2008. ,
DOI : 10.1016/j.devcel.2008.11.010
Genetic dissection of the Down syndrome critical region, Human Molecular Genetics, vol.24, issue.22, pp.6540-6551, 2015. ,
DOI : 10.1093/hmg/ddv364
Partial BACE1 reduction in a Down syndrome mouse model blocks Alzheimer-related endosomal anomalies and cholinergic neurodegeneration: role of APP-CTF, Neurobiology of Aging, vol.39, pp.90-98, 2016. ,
DOI : 10.1016/j.neurobiolaging.2015.11.013
Infantile spasms in down syndrome: Rescue by knockdown of the GIRK2 channel, Annals of Neurology, vol.13, issue.suppl, pp.511-521, 2016. ,
DOI : 10.1586/ern.13.48
The importance of understanding individual differences in Down syndrome, F1000Research, vol.5, 2016. ,
DOI : 10.12688/f1000research.7506.1
Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome, Current Alzheimer Research, vol.13, issue.1, pp.84-96, 2016. ,
DOI : 10.2174/1567205012666150921100515
Neural Stem Cells Reduce Hippocampal Tau and Reelin Accumulation in Aged Ts65Dn down Syndrome Mice, Cell Transplantation, vol.480, issue.3, pp.371-379, 2011. ,
DOI : 10.1002/cne.20344
Paper 2: EUROCAT public health indicators for congenital anomalies in Europe, Birth Defects Research Part A: Clinical and Molecular Teratology, vol.349, issue.S1, pp.16-22, 2011. ,
DOI : 10.1016/S0140-6736(96)07495-8
URL : https://hal.archives-ouvertes.fr/inserm-00578498
Long-term running alleviates some behavioral and molecular abnormalities in Down syndrome mouse model Ts65Dn, Experimental Neurology, vol.240, pp.178-189, 2013. ,
DOI : 10.1016/j.expneurol.2012.11.022
Hippocampal Long-Term Potentiation Suppressed by Increased Inhibition in the Ts65Dn Mouse, a Genetic Model of Down Syndrome, Journal of Neuroscience, vol.24, issue.37, 2004. ,
DOI : 10.1523/JNEUROSCI.1766-04.2004
Deficits in Cognition and Synaptic Plasticity in a Mouse Model of Down Syndrome Ameliorated by GABAB Receptor Antagonists, Journal of Neuroscience, vol.32, issue.27, pp.9217-9227, 2012. ,
DOI : 10.1523/JNEUROSCI.1673-12.2012
Increased efficiency of the REVIEW Disease Models & Mechanisms, pp.1165-1186, 2012. ,
The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies, Proc. Natl. Acad. Sci. USA, pp.12031-12036, 2009. ,
DOI : 10.1038/ejhg.2008.214
Down syndrome phenotypes: the consequences of chromosomal imbalance, Proc. Natl. Acad. Sci. USA 91, pp.4997-5001, 1994. ,
Successful Aging in a 70-Year-Old Man With Down Syndrome: A Case Study, Intellectual and Developmental Disabilities, vol.46, issue.3, pp.215-228, 2008. ,
DOI : 10.1352/2008.46:215-228
Down syndrome in diverse populations, American Journal of Medical Genetics Part A, vol.18, issue.1, pp.42-53, 2017. ,
DOI : 10.1016/j.media.2014.04.002
Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development, BMC Genomics, vol.10, issue.1, p.138, 2009. ,
DOI : 10.1186/1471-2164-10-138
URL : https://hal.archives-ouvertes.fr/hal-00804586
Triplication of DYRK1A causes retinal structural and functional alterations in Down syndrome, Human Molecular Genetics, vol.22, issue.14, pp.2775-2784, 2013. ,
DOI : 10.1093/hmg/ddt125
Chronic P7C3 treatment restores hippocampal neurogenesis, Neuroscience Letters, vol.591, pp.86-92, 2015. ,
DOI : 10.1016/j.neulet.2015.02.008
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363293/pdf
Bidirectional modulation of fear extinction by mediodorsal thalamic firing in mice, Nature Neuroscience, vol.68, issue.2, pp.308-314, 2011. ,
DOI : 10.1523/JNEUROSCI.3126-09.2009
Domains of genome-wide gene expression dysregulation in Down???s syndrome, Nature, vol.13, issue.7496, pp.345-350, 2014. ,
DOI : 10.1186/gb-2012-13-10-r87
Duplication of the entire 22.9??Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities, Human Molecular Genetics, vol.16, issue.11, pp.1359-1366, 2007. ,
DOI : 10.1093/hmg/ddm086
Penetrance of Congenital Heart Disease in a Mouse Model of Down Syndrome Depends on a Trisomic Potentiator of a Disomic Modifier, Genetics, vol.203, issue.2, pp.763-770, 2016. ,
DOI : 10.1534/genetics.116.188045
Altered heart rate control in transgenic mice carrying the KCNJ6 gene of the human chromosome 21, Physiological Genomics, vol.33, issue.2, pp.230-239, 2008. ,
DOI : 10.1152/physiolgenomics.00143.2007
Genetic analysis of Down syndrome-associated heart defects in mice, Human Genetics, vol.19, issue.5, pp.623-632, 2011. ,
DOI : 10.1093/hmg/ddq179
Engineered chromosome-based genetic mapping establishes a 3.7??Mb critical genomic region for Down syndrome-associated heart defects in mice, Human Genetics, vol.3, issue.205, pp.743-753, 2014. ,
DOI : 10.4161/bbug.3.1.17696
Effects of voluntary physical exercise on adult hippocampal neurogenesis and behavior of Ts65Dn mice, a model of Down syndrome, Neuroscience, vol.171, issue.4, pp.1228-1240, 2010. ,
DOI : 10.1016/j.neuroscience.2010.09.043
Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening, European Journal of Human Genetics, vol.30, issue.1, pp.27-33, 2013. ,
DOI : 10.1002/pd.1443
Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model, Experimental Neurology, vol.216, issue.2, pp.278-289, 2009. ,
DOI : 10.1016/j.expneurol.2008.11.021
Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome, Behavioural Brain Research, vol.221, issue.2, pp.610-622, 2011. ,
DOI : 10.1016/j.bbr.2010.03.036
A new mouse model for the trisomy of the Abcg1???U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome, Human Molecular Genetics, vol.18, issue.24, pp.4756-4769, 2009. ,
DOI : 10.1093/hmg/ddp438
Genotype???phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21, European Journal of Human Genetics, vol.49, issue.4, pp.454-466, 2009. ,
DOI : 10.1086/520000
Monoacylglycerol Lipase Inhibitor JZL184 Improves Behavior and Neural Properties in Ts65Dn Mice, a Model of Down Syndrome, PLoS ONE, vol.34, issue.12, 2014. ,
DOI : 10.1371/journal.pone.0114521.s003
Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome, Journal of Clinical Investigation, vol.122, issue.3, pp.948-962, 2012. ,
DOI : 10.1172/JCI60455DS1
Dosage of the Abcg1-U2af1 Region Modifies Locomotor and Cognitive Deficits Observed in the Tc1 Mouse Model of Down Syndrome, PLOS ONE, vol.21, issue.2, 2015. ,
DOI : 10.1371/journal.pone.0115302.t001
Reducing GABAA ??5 Receptor-Mediated Inhibition Rescues Functional and Neuromorphological Deficits in a Mouse Model of Down Syndrome, Journal of Neuroscience, vol.33, issue.9, pp.3953-3966, 2013. ,
DOI : 10.1523/JNEUROSCI.1203-12.2013
Motor phenotypic alterations in TgDyrk1a transgenic mice implicate DYRK1A in Down syndrome motor dysfunction, Neurobiology of Disease, vol.15, issue.1, pp.132-142, 2004. ,
DOI : 10.1016/j.nbd.2003.10.002
The fear circuit of the mouse forebrain: connections between the mediodorsal thalamus, frontal cortices and basolateral amygdala, European Journal of Neuroscience, vol.995, issue.11, pp.1810-1823, 2014. ,
DOI : 10.1016/j.brainres.2003.10.006
An overview of evidence for a causal relationship between dietary availability of choline during development and cognitive function in offspring, Neuroscience & Biobehavioral Reviews, vol.30, issue.5, pp.696-712, 2006. ,
DOI : 10.1016/j.neubiorev.2005.12.003
Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome, Hum. Mol. Genet, vol.25, pp.4856-4869, 2016. ,
Trans effects of chromosome aneuploidies on DNA methylation patterns in human Down syndrome and mouse models, Genome Biology, vol.5, issue.Suppl 4, p.263, 2015. ,
DOI : 10.1371/journal.pone.0008394
Perinatal choline supplementation improves cognitive functioning and emotion regulation in the Ts65Dn mouse model of Down syndrome., Behavioral Neuroscience, vol.124, issue.3, pp.346-361, 2010. ,
DOI : 10.1037/a0019590
Postnatal lethality and cardiac anomalies in the Ts65Dn Down Syndrome mouse model, Mammalian Genome, vol.359, issue.10, pp.1005-1012, 2006. ,
DOI : 10.1007/s00335-006-0032-8
Increased male reproductive success in Ts65Dn ???Down syndrome??? mice, Mammalian Genome, vol.237, issue.11-12, pp.543-549, 2010. ,
DOI : 10.1007/s00335-010-9300-8
The effects of piracetam on cognitive performance in a mouse model of Down's syndrome, Physiology & Behavior, vol.77, issue.2-3, pp.403-409, 2002. ,
DOI : 10.1016/S0031-9384(02)00873-9
Developments of a water-maze procedure for studying spatial learning in the rat, Journal of Neuroscience Methods, vol.11, issue.1, pp.47-60, 1984. ,
DOI : 10.1016/0165-0270(84)90007-4
Estimating the risk of Down's syndrome in antenatal screening and the gestation at which this risk applies, Journal of Medical Screening, vol.14, issue.1, pp.5-7, 2007. ,
DOI : 10.1258/096914107780154549
Fetal loss in Down syndrome pregnancies, Prenatal Diagnosis, vol.306, issue.2, pp.142-145, 1999. ,
DOI : 10.1111/j.1471-0528.1995.tb10845.x
PCP4 (PEP19) overexpression induces premature neuronal differentiation associated with Ca(2+) /calmodulindependent kinase II delta activation in mouse models of down syndrome, J. Comp. Neurol, vol.63, pp.92-106, 2011. ,
Developmental molecular and functional cerebellar alterations induced by PCP4/PEP19 overexpression: Implications for Down syndrome, Neurobiology of Disease, vol.63, pp.92-106, 2014. ,
DOI : 10.1016/j.nbd.2013.11.016
URL : https://hal.archives-ouvertes.fr/hal-01179506
Prenatal diagnosis of Down syndrome: a systematic review of termination rates (1995-2011), Prenatal Diagnosis, vol.33, issue.3, pp.142-153, 1995. ,
DOI : 10.1002/uog.6233
Lowering beta-amyloid levels rescues learning and memory in a Down syndrome mouse model, PLoS ONE, vol.5, 2010. ,
Early Lineage Priming by Trisomy of Erg Leads to Myeloproliferation in a Down Syndrome Model, PLOS Genetics, vol.113, issue.5, 2015. ,
DOI : 10.1371/journal.pgen.1005211.s006
An Aneuploid Mouse Strain Carrying Human Chromosome 21 with Down Syndrome Phenotypes, Science, vol.309, issue.5743, pp.2033-2037, 2005. ,
DOI : 10.1126/science.1114535
Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination, Neuron, vol.89, issue.6, pp.1208-1222, 2016. ,
DOI : 10.1016/j.neuron.2016.01.042
URL : https://doi.org/10.1016/j.neuron.2016.01.042
Longitudinal measures of cognition in the Ts65Dn mouse: Refining windows and defining modalities for therapeutic intervention in Down syndrome, Experimental Neurology, vol.279, pp.40-56, 2016. ,
DOI : 10.1016/j.expneurol.2016.02.005
A Chromosome 21 Critical Region Does Not Cause Specific Down Syndrome Phenotypes, Science, vol.306, issue.5696, pp.687-690, 2004. ,
DOI : 10.1126/science.1098992
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019810/pdf
Targeting Dyrk1A with AAVshRNA Attenuates Motor Alterations in TgDyrk1A, a Mouse Model of Down Syndrome, The American Journal of Human Genetics, vol.83, issue.4, pp.479-488, 2008. ,
DOI : 10.1016/j.ajhg.2008.09.010
Alterations of Endocannabinoid Signaling, Synaptic Plasticity, Learning, and Memory in Monoacylglycerol Lipase Knock-out Mice, Journal of Neuroscience, vol.31, issue.38, pp.13420-13430, 2011. ,
DOI : 10.1523/JNEUROSCI.2075-11.2011
Dyrk1A Phosphorylates p53 and Inhibits Proliferation of Embryonic Neuronal Cells, Journal of Biological Chemistry, vol.17, issue.41, pp.31895-31906, 2010. ,
DOI : 10.1093/hmg/ddp047
Dyrk1A negatively regulates the actin cytoskeleton through threonine phosphorylation of N-WASP, Journal of Cell Science, vol.125, issue.1, pp.67-80, 2012. ,
DOI : 10.1242/jcs.086124
Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006, Birth Defects Research Part A: Clinical and Molecular Teratology, vol.146, issue.Suppl 2, pp.1008-1016, 2004. ,
DOI : 10.1001/archpedi.1992.02160190089028
RCAN1 links impaired neurotrophin trafficking to aberrant development of the sympathetic nervous system in Down syndrome, Nature Communications, vol.27, 2015. ,
DOI : 10.1016/S0896-6273(00)00061-1
DBA/2 and C57BL/6 mice differ in contextual fear but not auditory fear conditioning., Behavioral Neuroscience, vol.108, issue.4, pp.810-817, 1994. ,
DOI : 10.1037/0735-7044.108.4.810
A Syntenic Cross Species Aneuploidy Genetic Screen Links RCAN1 Expression to ??-Cell Mitochondrial Dysfunction in Type 2 Diabetes, PLOS Genetics, vol.41, issue.Supplement, 2016. ,
DOI : 10.1371/journal.pgen.1006033.s004
The pattern of congenital heart defects arising from reduced Tbx5 expression is altered in a Down syndrome mouse model, BMC Developmental Biology, vol.252, issue.1, p.30, 2015. ,
DOI : 10.1006/dbio.2002.0835
Environmental enrichment rescues DYRK1A activity and hippocampal adult neurogenesis in TgDyrk1A, Neurobiology of Disease, vol.60, pp.18-31, 2013. ,
DOI : 10.1016/j.nbd.2013.08.008
Dyrk1A induces pancreatic ?? cell mass expansion and improves glucose tolerance, Cell Cycle, vol.1, issue.14, pp.2221-2229, 2014. ,
DOI : 10.2337/db11-0765
URL : http://www.tandfonline.com/doi/pdf/10.4161/cc.29250?needAccess=true
New cerebellar phenotypes in YAC transgenic mouse in vivo library of human Down syndrome critical region-1, Biochemical and Biophysical Research Communications, vol.364, issue.3, pp.488-494, 2007. ,
DOI : 10.1016/j.bbrc.2007.10.035
Effects of Neonatal Neural Progenitor Cell Implantation on Adult Neuroanatomy and Cognition in the Ts65Dn Model of Down Syndrome, PLoS ONE, vol.3, issue.4, p.36082, 2012. ,
DOI : 10.1371/journal.pone.0036082.s007
Chromosome engineering in mice, Nature, vol.201, issue.6558, pp.720-724, 1995. ,
DOI : 10.1128/MCB.14.4.2404
The App-Runx1 Region Is Critical for Birth Defects and Electrocardiographic Dysfunctions Observed in a Down Syndrome Mouse Model, PLoS Genetics, vol.3, issue.5, 2012. ,
DOI : 10.1371/journal.pgen.1002724.s003
dose-dependent cilia dysfunction., Human Molecular Genetics, vol.26, pp.923-931, 2017. ,
DOI : 10.1093/hmg/ddx007
A mouse model for Down syndrome exhibits learning and behaviour deficits, Nature Genetics, vol.5, issue.2, pp.177-184, 1995. ,
DOI : 10.1016/0092-8674(86)90493-9
Brain phenotype of transgenic mice overexpressing cystathionine ?-synthase, PLoS One, vol.7, 2012. ,
Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn, Mammalian Genome, vol.19, issue.11-12, pp.685-691, 2011. ,
DOI : 10.1101/gr.073585.107
Tumour angiogenesis is reduced in the Tc1 mouse model of Down???s syndrome, Nature, vol.49, issue.7299, pp.813-817, 2010. ,
DOI : 10.1091/mbc.11.9.2915
Parallels of craniofacial maldevelopment in down syndrome and Ts65Dn mice, Developmental Dynamics, vol.5, issue.2, pp.137-145, 2000. ,
DOI : 10.1177/000992286600500812
Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome, American Journal of Medical Genetics, vol.26, issue.4, pp.317-324, 2002. ,
DOI : 10.1177/000992286600500812
Down's syndrome, The Lancet, vol.361, issue.9365, pp.1281-1289, 2003. ,
DOI : 10.1016/S0140-6736(03)12987-X
Understanding the Basis for Down Syndrome Phenotypes, PLoS Genetics, vol.44, issue.3, p.50, 2006. ,
DOI : 1545-5017(2005)044[0040:GMIDSI]2.0.CO;2
Defective cerebellar response to mitogenic Hedgehog signaling in Down [corrected] syndrome mice, Proc. Natl. Acad. Sci. USA 103, pp.1452-1456, 2006. ,
Pre-weaning Sensorial and Motor Development in Mice Transpolygenic for the Critical Region of Trisomy 21, Behavior Genetics, vol.108, issue.3, pp.377-386, 2006. ,
DOI : 10.1007/s10519-006-9055-x
APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy, Nature Genetics, vol.302, issue.1, pp.24-26, 2006. ,
DOI : 10.1212/WNL.56.7.979
APP locus duplication in a Finnish family with dementia and intracerebral haemorrhage, Journal of Neurology, Neurosurgery & Psychiatry, vol.78, issue.10, pp.1158-1159, 2007. ,
DOI : 10.1136/jnnp.2006.113514
Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome, Neuroscience Letters, vol.433, issue.1, pp.22-27, 2008. ,
DOI : 10.1016/j.neulet.2007.12.039
Effects of chronic administration of SGS-111 during adulthood and during the pre- and post-natal periods on the cognitive deficits of Ts65Dn mice, a model of Down syndrome, Behavioural Brain Research, vol.188, issue.2, pp.355-367, 2008. ,
DOI : 10.1016/j.bbr.2007.11.020
Memantine Normalizes Several Phenotypic Features in the Ts65Dn Mouse Model of Down Syndrome, Journal of Alzheimer's Disease, vol.21, issue.1, pp.277-290, 2010. ,
DOI : 10.3233/JAD-2010-100240
Large-scale analysis of the regulatory architecture of the mouse genome with a transposon-associated sensor, Nature Genetics, vol.139, issue.4, pp.379-386, 2011. ,
DOI : 10.1002/dvdy.21482
Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities, Proc. Natl, 1998. ,
DOI : 10.1038/39315
Cognition and Hippocampal Plasticity in the Mouse Is Altered by Monosomy of a Genomic Region Implicated in Down Syndrome, Genetics, vol.197, issue.3, pp.899-912, 2014. ,
DOI : 10.1534/genetics.114.165241
Increased App Expression in a Mouse Model of Down's Syndrome Disrupts NGF Transport and Causes Cholinergic Neuron Degeneration, Neuron, vol.51, issue.1, pp.29-42, 2006. ,
DOI : 10.1016/j.neuron.2006.05.022
Restoration of Norepinephrine-Modulated Contextual Memory in a Mouse Model of Down Syndrome, Science Translational Medicine, vol.277, issue.16, pp.7-17, 2009. ,
DOI : 10.1016/S0024-3205(00)00787-6
Influence of Genetic Background on Knockout Mouse Phenotypes, Methods Mol. Biol, vol.158, pp.217-225, 2001. ,
DOI : 10.1385/1-59259-220-1:217
Experience-dependent reduction of soluble ??-amyloid oligomers and rescue of cognitive abilities in middle-age Ts65Dn mice, a model of Down syndrome, Experimental Neurology, vol.283, pp.49-56, 2016. ,
DOI : 10.1016/j.expneurol.2016.06.006
Increased Dosage ofDYRK1A and Brain Volumetric Alterations in a YAC Model of Partial Trisomy 21, The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology, vol.934, issue.3, pp.254-262, 2008. ,
DOI : 10.1212/WNL.45.2.356
Epidemiology of Down syndrome, Mental Retardation and Developmental Disabilities Research Reviews, vol.58, issue.3, pp.221-227, 2007. ,
DOI : 10.1037/11220-000
alpha-Tocopherol suppresses lipid peroxidation and behavioral and cognitive impairments in the Ts65Dn mouse model of Down syndrome. Free Radic, Biol. Med, vol.50, pp.1801-1811, 2011. ,
Genetic Background Limits Generalizability of Genotype-Phenotype Relationships, Neuron, vol.91, issue.6, pp.1253-1259, 2016. ,
DOI : 10.1016/j.neuron.2016.08.013
Functional screening and complex traits: human 21q22.2 sequences affecting learning in mice, Human Molecular Genetics, vol.6, issue.10, pp.1729-1733, 1997. ,
DOI : 10.1093/hmg/6.10.1729
Construction of a Panel of Transgenic Mice Containing a Contiguous 2-Mb Set of YAC/P1 Clones from Human Chromosome 21q22.2, Genomics, vol.27, issue.3, pp.425-434, 1995. ,
DOI : 10.1006/geno.1995.1073
Dyrk1A-mediated phosphorylation of RCAN1 promotes the formation of insoluble RCAN1 aggregates, Neuroscience Letters, vol.554, pp.135-140, 2013. ,
DOI : 10.1016/j.neulet.2013.08.066
Phosphorylation and Inactivation of Glycogen Synthase Kinase 3?? (GSK3??) by Dual-specificity Tyrosine Phosphorylation-regulated Kinase 1A (Dyrk1A), Journal of Biological Chemistry, vol.296, issue.4, pp.2321-2333, 2015. ,
DOI : 10.1128/MCB.00580-06
Excitation/inhibition balance and learning are modified by Dyrk1a gene dosage, Neurobiology of Disease, vol.69, pp.65-75, 2014. ,
DOI : 10.1016/j.nbd.2014.04.016
Pharmacological correction of excitation/inhibition imbalance in Down syndrome mouse models, Frontiers in Behavioral Neuroscience, vol.79, p.267, 2015. ,
DOI : 10.1111/j.1399-0004.2010.01544.x
URL : https://hal.archives-ouvertes.fr/hal-01263753
Pharmacotherapy with Fluoxetine Restores Functional Connectivity from the Dentate Gyrus to Field CA3 in the Ts65Dn Mouse Model of Down Syndrome, PLoS ONE, vol.24, issue.4, 2013. ,
DOI : 10.1371/journal.pone.0061689.g010
Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice, Neurobiology of Disease, vol.74, pp.204-218, 2015. ,
DOI : 10.1016/j.nbd.2014.12.005
Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome, Neuroscience, vol.333, pp.277-301, 2016. ,
DOI : 10.1016/j.neuroscience.2016.07.031
The Open Field Test: reinventing the wheel, Journal of Psychopharmacology, vol.21, issue.2, pp.134-135, 2007. ,
DOI : 10.1037/0033-2909.83.3.482
Overlapping trisomies for human chromosome 21 orthologs produce similar effects on skull and brain morphology of Dp(16)1Yey and Ts65Dn mice, American Journal of Medical Genetics Part A, vol.18, issue.8, pp.1981-1990, 2014. ,
DOI : 10.1093/hmg/ddp010
Prenatal Screening for Fetal Aneuploidy, Journal of Obstetrics and Gynaecology Canada, vol.29, issue.2, pp.146-179, 2007. ,
DOI : 10.1016/S1701-2163(16)32379-9
Trisomy represses ApcMin-mediated tumours in mouse models of Down???s syndrome, Nature, vol.20, issue.7174, pp.73-75, 2008. ,
DOI : 10.1038/nature06446
The Hedgehog and Wnt signaling pathways in cancer, Nature, vol.411, issue.6835, pp.349-354, 2001. ,
DOI : 10.1038/35077219
minibrain: A new protein kinase family involved in postembryonic neurogenesis in Drosophila, Neuron, vol.14, issue.2, pp.287-301, 1995. ,
DOI : 10.1016/0896-6273(95)90286-4
Prefrontal Deficits in a Murine Model Overexpressing the Down Syndrome Candidate Gene Dyrk1a, Journal of Neuroscience, vol.34, issue.4, pp.1138-1147, 2014. ,
DOI : 10.1523/JNEUROSCI.2852-13.2014
Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype, Science, vol.269, issue.5221, pp.230-234, 1995. ,
DOI : 10.1126/science.7618084
APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome, Human Molecular Genetics, vol.20, issue.8, pp.1560-1573, 2011. ,
DOI : 10.1093/hmg/ddr033
The Amyloid Precursor Protein (APP) Triplicated Gene Impairs Neuronal Precursor Differentiation and Neurite Development through Two Different Domains in the Ts65Dn Mouse Model for Down Syndrome, Journal of Biological Chemistry, vol.77, issue.29, pp.20817-20829, 2013. ,
DOI : 10.1073/pnas.0813248106
An Increase in Basal BDNF Provokes Hyperactivation of the Akt-Mammalian Target of Rapamycin Pathway and Deregulation of Local Dendritic Translation in a Mouse Model of Down's Syndrome, Journal of Neuroscience, vol.31, issue.26, pp.9445-9455, 2011. ,
DOI : 10.1523/JNEUROSCI.0011-11.2011
The Akt-mTOR Pathway in Down???s Syndrome: The Potential Use of Rapamycin/Rapalogs for Treating Cognitive Deficits, CNS & Neurological Disorders - Drug Targets, vol.13, issue.1, pp.34-40, 2014. ,
DOI : 10.2174/18715273113126660184
New techniques to understand chromosome dosage: mouse models of aneuploidy, Human Molecular Genetics, vol.15, issue.suppl_2, pp.103-109, 2006. ,
DOI : 10.1093/hmg/ddl179
Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome, Neurobiology of Disease, vol.58, pp.92-101, 2013. ,
DOI : 10.1016/j.nbd.2013.04.016
Motor Development and Neuropsychological Patterns in Persons with Down Syndrome, Behavior Genetics, vol.7, issue.3, pp.355-364, 2006. ,
DOI : 10.1017/S1355617704106073
Lack of behavioral and cognitive effects of chronic ethosuximide and gabapentin treatment in the Ts65Dn mouse model of Down syndrome, Neuroscience, vol.220, pp.158-168, 2012. ,
DOI : 10.1016/j.neuroscience.2012.06.031
Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes, BMC Genomics, vol.51, issue.1, p.229, 2011. ,
DOI : 10.1139/G07-100
Identification and characterization of a new Down syndrome model, )) 2Cje, resulting from a spontaneous Robertsonian fusion between T(17(16))65Dn and mouse Chromosome 12, pp.79-90, 2005. ,
Mechanisms of Deficient Cardiac Septation in the Mouse With Trisomy 16, Circulation Research, vol.84, issue.8, pp.897-905, 1999. ,
DOI : 10.1161/01.RES.84.8.897
A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome, Nature Reviews Neuroscience, vol.20, issue.9, pp.564-574, 2015. ,
DOI : 10.1038/srep08744
Promotion of Neuronal Plasticity by (???)-Epigallocatechin-3-Gallate, Neurochemical Research, vol.45, issue.5, pp.776-783, 2008. ,
DOI : 10.1007/s11064-007-9494-7
Creation and characterization of BAC-transgenic mice with physiological overexpression of epitope-tagged RCAN1 (DSCR1), Mammalian Genome, vol.107, issue.1-2, pp.30-43, 2013. ,
DOI : 10.1016/S0092-8674(01)00585-2
Mouse-based genetic modeling and analysis of Down syndrome, British Medical Bulletin, vol.120, issue.1, pp.111-122, 2016. ,
DOI : 10.1093/bmb/ldw040
Increased Skin Tumor Incidence and Keratinocyte Hyper-Proliferation in a Mouse Model of Down Syndrome, PLOS ONE, vol.23, issue.23, 2016. ,
DOI : 10.1371/journal.pone.0146570.s006
MOUSE GENOMIC TECHNOLOGIES: ENGINEERING CHROMOSOMAL REARRANGEMENTS IN MICE, Nature Reviews Genetics, vol.2, issue.10, pp.780-790, 2001. ,
DOI : 10.1038/35093564
Deficiencies in the region syntenic to human 21q22.3 cause cognitive deficits in mice, Mammalian Genome, vol.27, issue.5-6, pp.258-267, 2010. ,
DOI : 10.1002/ajmg.a.31519
A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions, Human Molecular Genetics, vol.19, issue.14, pp.2780-2791, 2010. ,
DOI : 10.1093/hmg/ddq179
Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice, Brain Research, vol.1366, pp.162-171, 2010. ,
DOI : 10.1016/j.brainres.2010.09.107
Human chromosome 21 orthologous region on mouse chromosome 17 is a major determinant of Down syndrome-related developmental cognitive deficits, Human Molecular Genetics, vol.23, issue.3, pp.578-589, 2014. ,
DOI : 10.1093/hmg/ddt446